urinary mrna and lupus disease flare
play

Urinary mRNA and Lupus Disease Flare Dr. CC Szeto Department of - PowerPoint PPT Presentation

Urinary mRNA and Lupus Disease Flare Dr. CC Szeto Department of Medicine & Therapeutics The Chinese University of Hong Kong Hypothetical model autoantigens lack of T cell extrinsic regulation trigger auto-reactive T cells recruitment


  1. Urinary mRNA and Lupus Disease Flare Dr. CC Szeto Department of Medicine & Therapeutics The Chinese University of Hong Kong

  2. Hypothetical model autoantigens lack of T cell extrinsic regulation trigger auto-reactive T cells recruitment of bystander T B cells lymphocyte and other produce mononuclear cells autoantibody susceptible patients immune renal inflammation, complex cell proliferation deposite in and fibrosis kidney

  3. Lymphocyte subsets

  4. Th1 / Th2 imbalance • 100 patients and 10 controls Conclusions: Patients with active lupus nephritis have increased T-bet and depressed GATA-3 expression in urinary sediment and kidney, indicating a predominant Th1 lymphocyte activation. Chan RW, et al. Rheumatol 2006; 45; 91-957.

  5. Does it predict subsequent flare? 1.0 Proportion of Patients without Lupus Flare 0.8 0.6 0.4 0.2 High T-bet / GATA-3 ratio Low T-bet / GATA-3 ratio 0.0 0 12 24 36 48 Weeks Conclusions: Patients with clinically quiescent lupus but increased T-bet to GATA-3 expression ratio in urinary sediment have a higher chance of disease flare, probably because of underlying Th1 lymphocyte activation. Chan RW, et al. Rheumatol 2006; 45; 91-957.

  6. Validation study • 60 quiescent SLE patients • urinary mRNA expression of T-bet and GATA-3 quantified by the RT-QPCR • patients were followed for 4 years for disease flare

  7. T-bet level is important (A) (B) 1.0 1.0 low T-bet 0.8 0.8 low T-bet survival free of major flare survival free of any flare 0.6 0.6 0.4 0.4 high T-bet 0.2 0.2 high T-bet log rank test, p = 0.001 log rank test, p = 0.001 0.0 0.0 0 12 24 36 48 0 12 24 36 48 follow up (months) follow up (months) Chan RW, et al. Rheumatol 2007; 46: 44-48.

  8. Cut-off value (A) (B) 1.0 1.0 0.8 0.8 T-bet expression 0.6 0.6 Sensitivity Sensitivity = 3-fold normal T-bet expression = 3-fold normal 0.4 0.4 0.2 0.2 AUC = 0.735 AUC = 0.790 0.0 0.0 0.0 0.2 0.4 0.6 0.8 1.0 0.0 0.2 0.4 0.6 0.8 1.0 1 - Specificity 1 - Specificity Chan RW, et al. Rheumatol 2007; 46: 44-48.

  9. Conclusion of this part • high urinary T-bet mRNA level was an independent predictor of lupus flare • possibilities – short term immune system (Th1) activity ? – baseline tendency of Th1 activation ?

  10. Other lymphocyte subsets • 78 patients with SLE nephritis with various disease activity • urinary mRNA levels of Th17-related cytokines Kwan BC, et al. Rheumatol 2009; 48: 1491-1497.

  11. Regulatory T cells • 2 studies with 98 patients with active lupus nephritis Wang G, et al. Rheumatol 2009; 48: 755-760. Luk CC, et al. J Rheumatol 2015; 42: 1150-1155.

  12. Is monitoring of urinary mRNA useful? • cohort of 134 adult SLE patients • prospectively followed for 56 weeks • identified 19 patients with a single disease flare • compared to 19 matched controls with no disease flare during the same period • mRNA levels of eight pre-defined target genes in their urinary sediment before disease flare were measured

  13. Change in serological markers Szeto CC, et al. Clinica Chimica Acta 2012; 413: 448-455.

  14. Change in inflammatory cytokine mRNA Szeto CC, et al. Clinica Chimica Acta 2012; 413: 448-455.

  15. Change in Th transcription factor mRNA Szeto CC, et al. Clinica Chimica Acta 2012; 413: 448-455.

  16. Major vs minor flares Szeto CC, et al. Clinica Chimica Acta 2012; 413: 448-455.

  17. Severity of flare and change in urinary mRNA Szeto CC, et al. Clinica Chimica Acta 2012; 413: 448-455.

  18. Summary • baseline urinary T-bet mRNA level in quiescent SLE patient is an independent risk factor of subsequent flare • serial monitoring of MCP-1, IL-17, GATA-3 and FOXP3 mRNA level in urinary sediment may provide an early clue for detecting disease flare

  19. Further research questions • predictive accuracy and cost-effectiveness when added on to current serological monitoring • optimal frequency of monitoring • role of pre-emptive treatment • prediction of refractory disease

  20. Acknowledgement • Nephrology: Bonnie Kwan, KM Chow, CB Leung • Rheumatology: LS Tam, Edmund Li • Pathology: Fernand Lai, Paul Choi • Laboratory: Rebecca Chan, G Wang, KB Lai, Cathy Luk • Nursing: Lee Wai Ching, Lau Miu Fong • These studies were supported in part by the Hong Kong Society of Nephrology Research Grant and the Chinese University of Hong Kong (CUHK) research account 6901031.

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend